Journal article
DNA repair pathways and their therapeutic potential in lung cancer
Joshua T Burgess, Laura V Croft, Nathan C Wallace, Sally-Anne Stephenson, Mark N Adams, Nicholas W Ashton, Benjamin Solomon, Ken O'Byrne, Derek J Richard
LUNG CANCER MANAGEMENT | FUTURE MEDICINE LTD | Published : 2014
DOI: 10.2217/LMT.14.12
Open access
Abstract
Lung cancer is the leading cause of cancer-related mortality. According to WHO, 1.37 million deaths occur globally each year as a result of this disease. More than 70 of these cases are associated with prior tobacco consumption and/or cigarette smoking, suggesting a direct causal relationship. The development and progression of lung cancer and other malignancies involves the loss of genetic stability, resulting in acquisition of cumulative genetic changes; this affords the cell increased malignant potential. As such, an understanding of the mechanisms through which these events may occur will potentially allow for development of new anticancer therapies. This review will address the associat..
View full abstractGrants
Funding Acknowledgements
NW Ashton is financially supported by a scholarship awarded by Cancer Council Queensland. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.